Alesco Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,617
| Closed | -$206K | – | 173 |
|
|
2023
Q2 | $206K | Hold |
5,617
| – | – | 0.01% | 161 |
|
|
2023
Q1 | $229K | Buy |
5,617
+17
| +0.3% | +$734 | 0.01% | 155 |
|
|
2022
Q4 | $287K | Sell |
5,600
-116
| -2% | -$5.56K | 0.01% | 144 |
|
|
2022
Q3 | $250K | Buy |
5,716
+1,700
| +42% | +$82.6K | 0.01% | 133 |
|
|
2022
Q2 | $211K | Sell |
4,016
-30
| -0.7% | -$1.53K | 0.01% | 142 |
|
|
2022
Q1 | $209K | Sell |
4,046
-204
| -5% | -$10.6K | 0.01% | 143 |
|
|
2021
Q4 | $251K | Buy |
+4,250
| New | +$211K | 0.01% | 132 |
|
|
2019
Q3 | – | Sell |
-6,905
| Closed | -$284K | – | 134 |
|
|
2019
Q2 | $284K | Buy |
+6,905
| New | +$274K | 0.02% | 116 |
|
|
2017
Q4 | – | Sell |
-12,683
| Closed | -$430K | – | 121 |
|
|
2017
Q3 | $430K | Buy |
12,683
+2,144
| +20% | +$68.9K | 0.03% | 97 |
|
|
2017
Q2 | $336K | Sell |
10,539
-211
| -2% | -$6.65K | 0.02% | 97 |
|
|
2017
Q1 | $349K | Sell |
10,750
-5,091
| -32% | -$161K | 0.02% | 100 |
|
|
2016
Q4 | $488K | Sell |
15,841
-4,179
| -21% | -$128K | 0.04% | 86 |
|
|
2016
Q3 | $643K | Buy |
20,020
+2,677
| +15% | +$89.5K | 0.05% | 74 |
|
|
2016
Q2 | $579K | Hold |
17,343
| – | – | 0.05% | 74 |
|
|
2016
Q1 | $488K | Sell |
17,343
-2,972
| -15% | -$84.9K | 0.04% | 77 |
|
|
2015
Q4 | $622K | Sell |
20,315
-274
| -1% | -$8.62K | 0.05% | 70 |
|
|
2015
Q3 | $614K | Hold |
20,589
| – | – | 0.06% | 71 |
|
|
2015
Q2 | $655K | Buy |
20,589
+3,531
| +21% | +$115K | 0.06% | 72 |
|
|
2015
Q1 | $563K | Hold |
17,058
| – | – | 0.05% | 72 |
|
|
2014
Q4 | $504K | Sell |
17,058
-817
| -5% | -$23.4K | 0.05% | 74 |
|
|
2014
Q3 | $501K | Buy |
17,875
+817
| +5% | +$22.9K | 0.05% | 71 |
|
|
2014
Q2 | $480K | Hold |
17,058
| – | – | 0.05% | 72 |
|
|
2014
Q1 | $520K | Buy |
+17,058
| New | +$509K | 0.05% | 66 |
|
Other funds holding PFE
